![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2023
Bücklein, Veit; Perez, Ariel; Rejeski, Kai; Iacoboni, Gloria; Jurinovic, Vindi; Holtick, Udo; Penack, Olaf; Kharboutli, Soraya; Blumenberg, Viktoria; Ackermann, Josephine; Frölich, Lisa; Johnson, Grace; Patel, Kedar; Arciola, Brian; Mhaskar, Rahul; Wood, Anthony; Schmidt, Christian; Albanyan, Omar; Gödel, Philipp; Hoster, Eva 
ORCID: https://orcid.org/0000-0002-0749-1389; Bullinger, Lars; Mackensen, Andreas; Locke, Frederick; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Barba, Pere; Subklewe, Marion und Jain, Michael D.
(2023):
Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use.
In: HemaSphere, Bd. 7, Nr. 8, e907
ORCID: https://orcid.org/0000-0002-0749-1389; Bullinger, Lars; Mackensen, Andreas; Locke, Frederick; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Barba, Pere; Subklewe, Marion und Jain, Michael D.
(2023):
Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use.
In: HemaSphere, Bd. 7, Nr. 8, e907
Blumenberg, Viktoria ORCID: https://orcid.org/0000-0003-1379-0876; Galina, Busch; Baumann, Stephan ORCID: https://orcid.org/0009-0001-2804-2072; Jitschin, Regina; Iacoboni, Gloria ORCID: https://orcid.org/0000-0003-0805-9288; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Gallur, Laura ORCID: https://orcid.org/0000-0001-6293-9281; Iraola-Truchuelo, Josu ORCID: https://orcid.org/0000-0002-9909-3715; Winkelmann, Michael; Hellwig, Konstantin ORCID: https://orcid.org/0000-0001-9001-2176; Schmidt, Christian; Frölich, Lisa; Tast, Benjamin; Hildebrand, Friederike; Rejeski, Kai ORCID: https://orcid.org/0000-0003-3905-0251; Dekorsy, Franziska J.; Schmidkonz, Christian; Bäuerle, Tobias; Kunz, Wolfgang G. ORCID: https://orcid.org/0000-0002-5021-1952; Mougiakakos, Dimitrios ORCID: https://orcid.org/0000-0002-2817-6660; Müller, Fabian ORCID: https://orcid.org/0000-0001-5487-5839; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Barba, Pere; Bücklein, Veit L. ORCID: https://orcid.org/0000-0001-7391-7280; Mackensen, Andreas ORCID: https://orcid.org/0000-0002-0685-4483; Völkl, Simon und Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469
(2023):
Early quantification of anti-CD19 CAR T-cells by flow cytometry predicts response in R/R DLBCL.
In: Blood Advances, Bd. 7, Nr. 22: S. 6844-6849
[PDF, 498kB]
ORCID: https://orcid.org/0000-0003-1379-0876; Galina, Busch; Baumann, Stephan ORCID: https://orcid.org/0009-0001-2804-2072; Jitschin, Regina; Iacoboni, Gloria ORCID: https://orcid.org/0000-0003-0805-9288; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Gallur, Laura ORCID: https://orcid.org/0000-0001-6293-9281; Iraola-Truchuelo, Josu ORCID: https://orcid.org/0000-0002-9909-3715; Winkelmann, Michael; Hellwig, Konstantin ORCID: https://orcid.org/0000-0001-9001-2176; Schmidt, Christian; Frölich, Lisa; Tast, Benjamin; Hildebrand, Friederike; Rejeski, Kai ORCID: https://orcid.org/0000-0003-3905-0251; Dekorsy, Franziska J.; Schmidkonz, Christian; Bäuerle, Tobias; Kunz, Wolfgang G. ORCID: https://orcid.org/0000-0002-5021-1952; Mougiakakos, Dimitrios ORCID: https://orcid.org/0000-0002-2817-6660; Müller, Fabian ORCID: https://orcid.org/0000-0001-5487-5839; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Barba, Pere; Bücklein, Veit L. ORCID: https://orcid.org/0000-0001-7391-7280; Mackensen, Andreas ORCID: https://orcid.org/0000-0002-0685-4483; Völkl, Simon und Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469
(2023):
Early quantification of anti-CD19 CAR T-cells by flow cytometry predicts response in R/R DLBCL.
In: Blood Advances, Bd. 7, Nr. 22: S. 6844-6849
[PDF, 498kB]
Rejeski, Kai ORCID: https://orcid.org/0000-0003-3905-0251; Wang, Yucai ORCID: https://orcid.org/0000-0002-1576-8341; Albanyan, Omar; Munoz, Javier; Sesques, Pierre ORCID: https://orcid.org/0000-0001-8264-822X; Iacoboni, Gloria; Lopez‐Corral, Lucia; Ries, Isabelle; Bücklein, Veit L.; Mohty, Razan; Dreyling, Martin; Baluch, Aliyah; Shah, Bijal ORCID: https://orcid.org/0000-0003-4328-6021; Locke, Frederick L.; Hess, Georg; Barba, Pere; Bachy, Emmanuel; Lin, Yi; Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469 und Jain, Michael D. ORCID: https://orcid.org/0000-0002-7789-1257
(2023):
The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL.
In: American Journal of Hematology, Bd. 98, Nr. 11: S. 1699-1710
[PDF, 2MB]
ORCID: https://orcid.org/0000-0003-3905-0251; Wang, Yucai ORCID: https://orcid.org/0000-0002-1576-8341; Albanyan, Omar; Munoz, Javier; Sesques, Pierre ORCID: https://orcid.org/0000-0001-8264-822X; Iacoboni, Gloria; Lopez‐Corral, Lucia; Ries, Isabelle; Bücklein, Veit L.; Mohty, Razan; Dreyling, Martin; Baluch, Aliyah; Shah, Bijal ORCID: https://orcid.org/0000-0003-4328-6021; Locke, Frederick L.; Hess, Georg; Barba, Pere; Bachy, Emmanuel; Lin, Yi; Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469 und Jain, Michael D. ORCID: https://orcid.org/0000-0002-7789-1257
(2023):
The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL.
In: American Journal of Hematology, Bd. 98, Nr. 11: S. 1699-1710
[PDF, 2MB]
2022
Rejeski, Kai ORCID: https://orcid.org/0000-0003-3905-0251; Perez, Ariel; Iacoboni, Gloria; Penack, Olaf; Bücklein, Veit; Jentzsch, Liv; Mougiakakos, Dimitrios; Johnson, Grace; Arciola, Brian; Carpio, Cecilia; Blumenberg, Viktoria; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Bullinger, Lars; Locke, Frederick L; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Mackensen, Andreas; Bethge, Wolfgang; Barba, Pere; Jain, Michael D ORCID: https://orcid.org/0000-0002-7789-1257 und Subklewe, Marion
(2022):
The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL.
In: Journal for ImmunoTherapy of Cancer, Bd. 10, e004475
[PDF, 5MB]
ORCID: https://orcid.org/0000-0003-3905-0251; Perez, Ariel; Iacoboni, Gloria; Penack, Olaf; Bücklein, Veit; Jentzsch, Liv; Mougiakakos, Dimitrios; Johnson, Grace; Arciola, Brian; Carpio, Cecilia; Blumenberg, Viktoria; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Bullinger, Lars; Locke, Frederick L; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Mackensen, Andreas; Bethge, Wolfgang; Barba, Pere; Jain, Michael D ORCID: https://orcid.org/0000-0002-7789-1257 und Subklewe, Marion
(2022):
The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL.
In: Journal for ImmunoTherapy of Cancer, Bd. 10, e004475
[PDF, 5MB]